How much does a box of Adagrasib cost?

Adagrasib (Adagrasib) is a drug that targets specific cancer gene mutations and belongs to a class of targeted therapy drugs called KRAS G12C inhibitors. KRAS is a common cancer-related gene, of which G12C mutation is one of the more common mutation forms. This mutation leads to malignant cell growth and the development of cancer.

Adagrasib is not currently available in the country, so patients cannot purchase it domestically and can only purchase adagrasib through overseas channels. Abroad, there is only the original American drug adagrasib, and the price is very high, as high as about 190,000 yuan.

The development of adagrasib is based on an in-depth understanding of the KRAS G12C mutation and aims to block the growth and spread of cancer cells by inhibiting the activity of this mutated gene. The drug has shown good efficacy and safety in clinical trials, providing a new treatment option for some lung cancer patients with KRAS G12C mutations.

Research results show thatadagrasibcan bind toKRAS G12Cprotein and block its signal transduction pathway, thus interfering with the survival and proliferation of cancer cells. This mechanism makes adagrasib a potentially revolutionary drug, bringing new hope to some cases of cancer caused by these mutations.

However, it is worth noting that although adagrasib's clinical trial results show significant potential, further research and monitoring are still needed in practical applications to ensure its long-term efficacy and safety. Researchers and doctors will continue to closely monitor the development of this drug in the hope of providing more effective treatment options for patients, especially those with cancers that have specific genetic mutations.